Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Actinogen Medical Ltd
ACWCurrent price
0.023 AUD
-0.001 AUD (-4.17%)
Last closed
0.024 AUD
Company
www.actinogen.com.au
ISIN
AU000000ACW3
Sector
Healthcare
Industry
Biotechnology
Exchange
Australian Securities Exchange
Capitalization
74 912 507 AUD
Yield for 12 month
+5.99 %
1Y
3Y
5Y
10Y
15Y
ACW
Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It develops Xanamem, an oral medication and inhibitor of the 11ß-HSD1 enzyme, which is in Phase 2 clinical trials, that achieves target engagement in the brain for the treatment of Alzheimer's disease, major depressive disorder, fragile x syndrome, and other neurological diseases. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia. Address: 109 Pitt Street, Sydney, NSW, Australia, 2000
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
0.23 AUDP/E ratio
–Dividend Yield
–Current Year
+10 056 134 AUD
Last Year
+4 949 274 AUD
Current Quarter
+9 135 697 AUD
Last Quarter
+920 437 AUD
Current Year
+9 634 072 AUD
Last Year
+4 538 575 AUD
Current Quarter
+8 928 264 AUD
Last Quarter
+705 810 AUD
Key Figures ACW
1 year
3 years
5 years
10 years
EBITDA
-13 083 318 AUD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-45.37 %
PEG Ratio
–
Return On Equity TTM
-78.81 %
Wall Street Target Price
0.23 AUD
Revenue TTM
10 056 135 AUD
Book Value
0.0071 AUD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
132.3 %
Dividend Yield
–
Gross Profit TTM
4 949 274 AUD
Earnings per share
-0.01 AUD
Diluted Eps TTM
-0.01 AUD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-131.34 %
Dividend Analytics ACW
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ACW
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:2
Payout Ratio
–
Last Split Date
03.12.2013
Dividend Date
–
Stock Valuation ACW
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
25.974
Enterprise Value Revenue
–
Price Sales TTM
7.4494
Enterprise Value EBITDA
-9.9502
Price Book MRQ
3.5997
Financials ACW
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ACW
For 52 weeks
0.02 AUD
0.1 AUD
50 Day MA
0.029 AUD
Shares Short Prior Month
–
200 Day MA
0.038 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart